The health edit
NUTRITION & HEALTHY AGING
Can a different diet change your biological age?
A small trial found changes in aging-related biomarkers. What that tells us—and what it leaves unanswered.
RECENTLY PUBLISHED
-
Tailored Grocery Boxes Did Not Clearly Beat Usual Food-Pantry Support in a Pilot Trial
A randomized pilot in 210 adults found no clear advantage for medically tailored grocery boxes over usual food-pantry support.
-
DASH Plus Lifestyle Counseling Shifted More Blood Markers—but Weight Loss Drove Much of the Change
A secondary analysis of 690 randomized PREMIER participants found broader metabolic-marker changes with DASH plus lifestyle counseling, while weight loss explained much of the pattern.
-
Gut-Friendly Diet Score Was Linked to Lower Mortality—but No Microbes Were Measured
A diet score designed around microbiome-related foods was associated with lower overall and cardiovascular mortality, but the observational study collected no direct gut-microbe measurements.
Recent research, explained
-
Tailored Grocery Boxes Did Not Clearly Beat Usual Food-Pantry Support in a Pilot Trial
A randomized pilot in 210 adults found no clear advantage for medically tailored grocery boxes over usual food-pantry support.
-
DASH Plus Lifestyle Counseling Shifted More Blood Markers—but Weight Loss Drove Much of the Change
A secondary analysis of 690 randomized PREMIER participants found broader metabolic-marker changes with DASH plus lifestyle counseling, while weight loss explained much of the pattern.
-
Gut-Friendly Diet Score Was Linked to Lower Mortality—but No Microbes Were Measured
A diet score designed around microbiome-related foods was associated with lower overall and cardiovascular mortality, but the observational study collected no direct gut-microbe measurements.
BEHIND THE HEADLINE
A younger biomarker profile isn’t proof of a longer life.
Research reported May 12, 2026 · Small randomized trial · 4 weeks
In a trial of 104 adults aged 65–75, several diet changes improved a biological-age estimate based on 20 biomarkers. The clearest statistical signal came from the omnivorous, higher-carbohydrate group.
The important limit: the trial did not establish longer life or fewer diseases. It excluded people with conditions including type 2 diabetes and cancer, so the findings cannot simply be applied to everyone.
From Let’s Talk Health
Full articles from 2025 onward on food, movement, and healthy aging.
-
SGLT2 Drugs Reduced Heart-Failure and Kidney Events Across 14 Diabetes Trials
A meta-analysis of 14 placebo-controlled trials found lower relative risks of heart-failure hospitalization, cardiovascular death, and composite kidney outcomes with SGLT2 inhibitors in adults with type 2 diabetes.
-
Brown Fat Looked Promising—but Losartan Evidence Is Not Yet Human
A large retrospective imaging study linked greater brown-fat activity with favorable cardiometabolic patterns, while losartan activated brown fat only in cell and mouse experiments.
-
Higher Paternal BMI Was Linked to Sperm DNA Methylation Differences
A human observational study links paternal BMI and age with sperm DNA methylation patterns, without proving effects on children.
-
Continuous Glucose Monitoring Lowered HbA1c Without Insulin in a 283-Person Trial
A 26-week randomized trial found that continuous glucose monitoring improved HbA1c and time in range among adults with type 2 diabetes who were not using insulin.
-
Three Lab Values Were Linked to Mortality Risk—but the Score Is Not Yet Ready for Clinical Use
A large U.S. observational study linked the EASIX laboratory score with mortality, but it has not been validated for routine CKM risk screening.
-
Coffee Stayed Steady—but Creamer Added More Calories
A national analysis found stable coffee intake but rising calories from add-ins, led by non-dairy creamer.
Curiosity.
With perspective.
Health headlines move quickly. Research briefs should link to their sources, identify the kind of evidence, and explain what remains unknown.
Human trials, observational studies, and animal experiments answer different questions. Promising findings deserve attention—and careful interpretation.